Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Belarus pharmaceutical market 2010

1,898 views

Published on

Belarus pharmaceutical market 2010

Published in: Health & Medicine, Travel
  • We are manufacturer of packaging machine for pharma, cosmetics and food beverage . if any contact us. My name is Rajeev Keshri and our mail address is salescis@sspackaginggroup.com.
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Be the first to like this

Belarus pharmaceutical market 2010

  1. 1. BELARUS:in prospect November 2010
  2. 2. Belarus Pharmaceutical MarketThe access to the pharmaceutical marketplace of any region is always paired with risks,challenges and political, financial and economical factors specific to each region.Belarus Facts and Figures An increase in the incidence of thyroid cancer has occurred among people who were young children and adolescents at the time of the accident and lived in theBelarus is divided into six regions or oblasts. The capital is Minsk, the country’s most contaminated areas. The accident has had a negative impact on the mentalpolitical, economic, scientific and cultural center. Mr. Alexander Lukashenko has health of the population, resulting in overuse of alcohol and tobacco.served as the President of the Republic of Belarus since July 1994. As of 1 January 2010, 10 690 cases of HIV infection had been registered. TheHealth challenges average HIV prevalence is 0.2–0.4%. The HIV epidemic is concentrated in injectingThe average life expectancy at birth is 70.4 years, almost 9 years below the average drug-users (10.7% in 2009) with a slightly growing HIV prevalence amongfor the WHO European Region and 3 years higher than the average for the commercial sex workers (2.9%) and men that have sex with men (2.1%). The leadingCommonwealth of Independent States (CIS) countries. mode of transmission is shifting from injecting drug use towards heterosexualLife expectancy is 76.2 years for women and 64.6 years for men. intercourse (the ratio of people infected through the heterosexual mode of transmission has been growing from 57.3% in 2005 to 77.6% in 2009).The leading causes of death are diseases of the circulatory system; external causessuch as accidents, poisoning, homicide and suicide; and cancer. Tuberculosis is an important public health issue; in 2008, there were 52.9 new cases and 8.7 deaths per 100 000. The spread of drug-resistant strains is a seriousUnhealthy lifestyles are a serious issue. In 2008, 27.5% of the population aged over concern.15 years reported smoking regularly and annual per capita alcohol consumption isestimated to be 11.74 liters, making tobacco and alcohol the most important risk Infant and maternal mortality rates are quite low: 5.2 per 1000 live births and 2.8factors in the country. They contribute particularly to premature mortality in males per 100 000 live births, respectively. These are significantly lower than thefrom diseases of the circulatory system (866 deaths per 100 000 population), which corresponding CIS averages: 12.8 and 27.4.is higher than the average for the European Region. SMD offers you an overview of the Belarus market, to support yourMortality in males from external causes of death (injury and poisoning) and lung knowledge of this market. We provide you the relevantcancer (242.6 and 69.5 deaths per 100 000, respectively) is also above the European information about opportunities as well as some threats in orderaverage. Nearly half of all deaths in motor vehicle accidents are related to alcoholabuse. to empower you to perform a successful launch, penetration orAlthough the birth rate is low, reproductive health is an important public health development of your pharmaceutical business.issue; 6.9% of live births are to mothers aged under 20 years. In addition, Belarushas a high abortion rate: an estimated 391.2 abortions per 1000 live births. Belarus:in prospect is available at Euros 120.00Suicide is another problem. The mortality rate from suicide and self-inflictedinjuries is one of the highest in the Region (25.3 deaths per 100 000): nearly twice To know more about our report or to discuss this topic further pleasethe Region’s average. do not hesitate to contact usEnvironmental health is an important issue for Belarus. About 1.5 million Tel/Fax: +38 044 206 17 17/18Belarusians live in areas polluted as a result of the Chernobyl accident in April 1986. e-mail: office@smd.net.ua
  3. 3. Belarus:in prospect CIS: Region Features Economic Development 5 Pharmaceutical Market: Executive Summary 6 Pharmaceutical Market: Main Features 7 Pharma Market Regional Structure 8 Belarus At a Glance 9 Economic Situation 10 Healthcare System 11 Belarus: Pharma Market Main Features 13 Key Data 14 Structure and Dynamics 15 ATC Classes Dynamics (retail segment) 16 ATC Classes Dynamics (original medicines) 17 ATC Classes Dynamics (generic medicines) 18 Leading Companies 19 Leading Originator Companies 20 Leading Generic Companies 21 Leading Companies in Rx segment 22 Leading Companies in OTC segment 23 Distributors 24 Pharmacies 25 Belarus: Forecast for 2010-2012 Retail Segment 28 Belarus:in prospect © 2010 SMD All information contained in this publication is copyrighted in the name of SMD (Support in Market Development), and as such no part of this publication may be reproduced, repackaged, redistributed, resold in whole or in any part, or used in any form or by any means graphic, electronic or mechanical, including photocopying, recording, taping, or by information storage or retrieval, or by any other means, without the express written consent of the publisher.DISCLAIMERAll information contained in this publication has been researched and compiled from sources believed to be accurate and reliable at the time of publishing. However, SMDaccepts no liability whatsoever for any loss or damage resulting from errors, inaccuracies or omissions affecting any part of the publication. All information is providedwithout warranty, and SMD makes no representation of warranty of any kind as to the accuracy or completeness of any information hereto contained.
  4. 4. SMD (Support in Market Development) - is a leading provider of market research,sales management and forecasting services to the pharmaceutical industry.Researches of:· Pharmaceutics establishments purchase and sale audit· Hospital establishments purchase audit· Second distribution audit Ukraine, 03680· Import medicine analyses Bojenko str., 86i, Kiev· Doctor prescription analyses Tel/Fax: +38 044 206 17 17/18· Ad Hoc research e-mail: office@smd.net.ua· Analytical services http://www.smd.net.ua BELARUS:in prospect November 2010

×